Autolus Therapeutics plc (AUTL)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-14) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-27) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 · 99.2 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 · 99.2 | ||
| 10-K | FY-2024 | 8-K (2025-03-20) · 99.1 · 99.2 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 · 99.2 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-17) · 99.1 · 99.2 | ||
| 10-K | FY-2023 | 8-K (2024-03-14) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Unaudited Condensed Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets (P) | ||
| Unaudited Condensed Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss (P) | ||
| Consolidated Statements of Shareholders Equity | ||
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (loss)(P) | — |
|
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (P) | — |
|
| Consolidated Statements of Changes In Shareholders Equity | ||
| Unaudited Condensed Consolidated Statements of Changes In Shareholders Equity | — |
|
| Unaudited Condensed Consolidated Statements of Shareholders Equity | — |
|
| Consolidated Statements of Cash Flows | ||
| Unaudited Condensed Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Changes In Shareholders Equity (P) | — |
|
| Notes | ||
| Accrued Expenses and Other Liabilities | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefit Plans | — |
|
| Fair Value Measurements | ||
| Geographic Information | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets, Net | ||
| Interest Expense | ||
| Interest Expense, Net | ||
| Inventories, Net | ||
| Leases | ||
| Liabilities Related To Future Royalties and Milestones, Net | ||
| Liability Related To Future Royalties and Sales Milestones, Net | — |
|
| Liability Related To Sales of Future Royalties and Sales Milestones, Net | — |
|
| License Agreements | — |
|
| License Revenue | ||
| Marketable Securities: Available-for-sale Debt Securities | ||
| Nature of The Business | ||
| Net Loss Per Ordinary Share | — |
|
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Parties | — |
|
| Related Party Transactions | ||
| Restatement of Previous-issued Quarterly Condensed Consolidated Financial Statements (unaudited) | — |
|
| Restatement of Previously-issued Consolidated Financial Statements | — |
|
| Revenue | ||
| Segment Reporting | ||
| Severance Plan | — |
|
| Share Based Compensation | — |
|
| Share-based Compensation | ||
| Share-based Compensation Expense | — |
|
| Shareholders Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrants | — |
|